Pharmaceutical

Otsuka and ShapeTX to develop gene therapies for eye diseases

Otsuka Pharmaceutical has entered a partnership with ShapeTX for the development of gene therapies to treat ocular diseases.

Sep 9, 2023 - 20:00
Otsuka and ShapeTX to develop gene therapies for eye diseases
Otsuka Pharmaceutical has entered a partnership with ShapeTX for the development of gene therapies to treat ocular diseases.
Read the original article

Tags:

Previous Article

Record number of respiratory syncytial virus (RSV) designations awarded in 2022

Next Article

NICE recommends Lilly’s tirzepatide to treat T2D

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT Virtual Event | Cancer’s Breakthrough Engine

STAT Virtual Event | Cancer’s Breakthrough Engine

Dec 19, 2023

STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional

STAT+: Oregon suspends a portion of its drug transparen...

Feb 23, 2024

Elsie and GSK link to accelerate oligonucleotide discovery platform

Elsie and GSK link to accelerate oligonucleotide discov...

Jul 11, 2023